165 related articles for article (PubMed ID: 21696789)
1. [Therapy-related acute leukemia: study of 23 pacients].
Motlló C; Sancho JM; García O; Granada I; Millá F; Ribera JM
Med Clin (Barc); 2011 Oct; 137(10):449-52. PubMed ID: 21696789
[TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
3. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
4. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of secondary leukemias.
Visani G; Pagano L; Pulsoni A; Tosi P; Piccaluga PP; Pastano R; Grafone T; Malagola M; Isidori A; Tura S
Leuk Lymphoma; 2000 May; 37(5-6):543-9. PubMed ID: 11042514
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors.
Takeyama K; Seto M; Uike N; Hamajima N; Ino T; Mikuni C; Kobayashi T; Maruta A; Muto Y; Maseki N; Sakamaki H; Saitoh H; Shimoyama M; Ueda R
Int J Hematol; 2000 Feb; 71(2):144-52. PubMed ID: 10745624
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related leukaemia--a clinical and scientific challenge.
Ng A; Taylor GM; Eden OB
Cancer Treat Rev; 2000 Oct; 26(5):377-91. PubMed ID: 11006138
[TBL] [Abstract][Full Text] [Related]
8. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
Larson RA
J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
[No Abstract] [Full Text] [Related]
9. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.
Ben-Yehuda D; Krichevsky S; Caspi O; Rund D; Polliack A; Abeliovich D; Zelig O; Yahalom V; Paltiel O; Or R; Peretz T; Ben-Neriah S; Yehuda O; Rachmilewitz EA
Blood; 1996 Dec; 88(11):4296-303. PubMed ID: 8943866
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
Fianchi L; Pagano L; Piciocchi A; Candoni A; Gaidano G; Breccia M; Criscuolo M; Specchia G; Maria Pogliani E; Maurillo L; Aloe-Spiriti MA; Mecucci C; Niscola P; Rossetti E; Mansueto G; Rondoni M; Fozza C; Invernizzi R; Spadea A; Fenu S; Buda G; Gobbi M; Fabiani E; Sica S; Hohaus S; Leone G; Voso MT
Am J Hematol; 2015 May; 90(5):E80-5. PubMed ID: 25653205
[TBL] [Abstract][Full Text] [Related]
12. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
Dührsen U
Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
[TBL] [Abstract][Full Text] [Related]
13. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines.
Ando M; Narabayashi M; Watanabe T; Kamiya Y; Togitani K; Tanosaki R; Takenaka T; Tobinai K; Adachi I
Jpn J Clin Oncol; 1999 Jan; 29(1):28-32. PubMed ID: 10073148
[TBL] [Abstract][Full Text] [Related]
15. [Four cases of therapy-related leukemia in multiple myeloma].
Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
[TBL] [Abstract][Full Text] [Related]
16. The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
Felix CA; Hosler MR; Provisor D; Salhany K; Sexsmith EA; Slater DJ; Cheung NK; Winick NJ; Strauss EA; Heyn R; Lange BJ; Malkin D
Blood; 1996 May; 87(10):4376-81. PubMed ID: 8639798
[TBL] [Abstract][Full Text] [Related]
17. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
18. [Second tumors developing after therapy for malignant tumors in children].
Kuleva SA; Kolygin BA
Vopr Onkol; 2012; 58(5):606-15. PubMed ID: 23600276
[TBL] [Abstract][Full Text] [Related]
19. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
[TBL] [Abstract][Full Text] [Related]
20. [Therapy related leukemia].
Fujisawa S; Maruta A; Sakai R; Ogawa K; Taguchi J; Tomita N; Kodama F; Fukawa H; Noguchi T; Matsuzaki M
Rinsho Ketsueki; 1995 Oct; 36(10):1163-9. PubMed ID: 8531325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
